These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

549 related items for PubMed ID: 4599351

  • 1. Introduction. Symposium on copper metabolism and Wilson's disease.
    Goldstein NP, Owen CA.
    Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
    [No Abstract] [Full Text] [Related]

  • 2. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S, Samuelson G, Sjölin S.
    Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP, Tauxe WN, McCall JT, Gross JB, Randall RV.
    Trans Am Neurol Assoc; 1969 Feb; 94():34-7. PubMed ID: 5374484
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of hepatolenticular degeneration. (Wilson's disease).
    Spellberg MA.
    Am J Gastroenterol; 1969 Aug; 52(2):121-6. PubMed ID: 4979739
    [No Abstract] [Full Text] [Related]

  • 5. Wilson's disease (hepatolenticular degeneration). Treatment with penicillamine and changes in hepatic trapping of radioactive copper.
    Goldstein NP, Tauxe WN, McCall JT, Randall RV, Gross JB.
    Arch Neurol; 1971 May; 24(5):391-400. PubMed ID: 5554863
    [No Abstract] [Full Text] [Related]

  • 6. Effects of penicillamine therapy and low-copper diet on dysarthria in Wilson's disease (hepatolenticular degeneration).
    Berry WR, Aronson AE, Darley FL, Goldstein NP.
    Mayo Clin Proc; 1974 Jun; 49(6):405-8. PubMed ID: 4835812
    [No Abstract] [Full Text] [Related]

  • 7. [2 cases of Wilson's disease diagnosed at the infra-clinical stage. Prolonged, early treatment using penicillamine. Result].
    Hamza B, el-Kamel M.
    Tunis Med; 1974 Jun; 52(1):29-31. PubMed ID: 4215182
    [No Abstract] [Full Text] [Related]

  • 8. What Wilson's disease and its treatment have taught us about the metabolism of copper. Observations in 27 cases.
    Goldstein NP, Tauxe WN, McCall JT, Randall RV, Gross JB.
    Med Clin North Am; 1968 Jul; 52(4):989-1001. PubMed ID: 5742073
    [No Abstract] [Full Text] [Related]

  • 9. Mutational analysis for Wilson's disease.
    Seto WK, Mak CM, But D, Hung I, Lam CW, Tam S, Yuen MF, Lai CL.
    Lancet; 2009 Aug 22; 374(9690):662. PubMed ID: 19700008
    [No Abstract] [Full Text] [Related]

  • 10. [Therapeutic considerations on Wilson's disease].
    Tavolato B, De Zanche L.
    G Psichiatr Neuropatol; 1966 Aug 22; 94(4):1085-93. PubMed ID: 5994293
    [No Abstract] [Full Text] [Related]

  • 11. [Wilson's disease (hepatolenticular degeneration)].
    Bickel H.
    Internist (Berl); 1966 Jan 22; 7(1):27-33 passim. PubMed ID: 4964272
    [No Abstract] [Full Text] [Related]

  • 12. [Hepatolenticular degeneration. Wilson's disease].
    Hansen HJ, Andersen OS.
    Ugeskr Laeger; 1969 Jul 31; 131(31):1301-5. PubMed ID: 4898805
    [No Abstract] [Full Text] [Related]

  • 13. Wilson's disease: a 1984 perspective.
    Ede RJ, Mowat AP.
    Compr Ther; 1984 Dec 31; 10(12):40-7. PubMed ID: 6518737
    [No Abstract] [Full Text] [Related]

  • 14. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A, Damato VD, Germinario L, Campanella G, Boccuni N.
    Acta Neurol (Napoli); 1971 Dec 31; 26(4):436-48. PubMed ID: 5132825
    [No Abstract] [Full Text] [Related]

  • 15. [New views on the etiology, diagnosis and therapy of Wilson's disease].
    Linke A.
    Z Arztl Fortbild (Jena); 1967 Dec 15; 61(24):1273-6. PubMed ID: 4873428
    [No Abstract] [Full Text] [Related]

  • 16. Abnormalities of the physiology of copper in Wilson's disease. I. The whole-body turnover of copper.
    O'Reilly S, Strickland GT, Weber PM, Beckner WM, Shipley L.
    Arch Neurol; 1971 May 15; 24(5):385-90. PubMed ID: 5554862
    [No Abstract] [Full Text] [Related]

  • 17. [Effects of the combined administration of glutathione and D-penicillamine on the urinary copper excretion in Wilson's disease].
    Atsuba Y, Nakahachi T, Terai T, Kozakai T.
    No To Shinkei; 1968 Feb 15; 20(2):187-95. PubMed ID: 5695072
    [No Abstract] [Full Text] [Related]

  • 18. Presymptomatic Wilson's disease.
    Levi AJ, Sherlock S, Scheuer PJ, Cumings JN.
    Lancet; 1967 Sep 16; 2(7516):575-9. PubMed ID: 4166824
    [No Abstract] [Full Text] [Related]

  • 19. The development of cirrhosis in Wilson's disease.
    Sternlieb I.
    Clin Gastroenterol; 1975 May 16; 4(2):367-79. PubMed ID: 1092490
    [No Abstract] [Full Text] [Related]

  • 20. Observations on copper metabolism in Wilson's disease.
    Czlonkowska A, Galewicz A, Rodo M, Wehr H.
    Acta Univ Carol Med Monogr; 1973 May 16; 56():175-7. PubMed ID: 4791768
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.